[Despite Challenges and Pitfalls: How Ophthalmology Benefits from the Use of Next-Generation Sequencing]

Area of Science:

• Ophthalmology
• Genetics
• Bioinformatics

Background:

• High-throughput sequencing, or next-generation sequencing (NGS), has become a standard in genetic diagnostics, largely supplanting Sanger sequencing.
• The interpretation of complex NGS data necessitates robust bioinformatic analysis to accurately identify disease-causing variants and prevent misinterpretations.

Purpose of the Study:

• To highlight the impact of NGS in diagnosing genetic eye disorders, using retinal dystrophies as a model.
• To emphasize the role of NGS in advancing ophthalmogenetic research and identifying novel disease genes.

Main Methods:

• Application of next-generation sequencing (NGS) for genetic analysis.
• Bioinformatic pipelines for processing and interpreting complex sequencing data.
• Focus on retinal dystrophies as a case study for genetic heterogeneity.

Main Results:

• NGS diagnostics provide significant and valuable information for the majority of patients and clinicians dealing with retinal dystrophies.
• The implementation of NGS has substantially enhanced our understanding of the genetic basis of these eye disorders.
• NGS has accelerated the pace of research in ophthalmogenetics, particularly in discovering new genes linked to eye diseases.

Conclusions:

• NGS is a transformative technology in diagnosing complex genetic disorders like retinal dystrophies.
• The continued development and application of NGS will further improve patient care and deepen our knowledge of ocular genetics.
• NGS plays a pivotal role in both clinical diagnostics and the discovery of novel genetic factors in ophthalmology.